13th Annual Fall Midwest Thoracic and GI Oncology Conference

 

13th Annual Fall Midwest Thoracic and GI Oncology Conference
Avatar

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/PDL-1 Therapy New Standard of Care, Mechanism of Immune Checkpoint Blockade, Immuno + Chemo & Future Directions

By 13th Annual Fall Midwest Thoracic and GI Oncology Conference FEATURING Manish R. Patel
By 13th Annual Fall Midwest Thoracic and GI Oncology Conference FEATURING Manish R. Patel
141 views
December 13, 2018
1 Comment
Login to view comments. Click here to Login

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser
Lung
40:51
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Lung Cancer in Former Smokers

Feat. M. Kessinger
36:16
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunotherapy for Metastatic NSCLC - Immunity Mechanisms, Anti-PD1/P…

Feat. M. Patel
17:31
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Current Issues and Potential Future Applications of Radiation Therap…

Feat. C. Zhang
20:02
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunomodulation from Local Radio Therapy in Lung Cancer

Feat. C. Zhang
23:01
13th Annual Fall Midwest Thoracic and GI Oncology Conference

How to Manage Relapsed SCLC & data from ImPower: Result of Atezo…

Feat. A. Ganti
15:10
13th Annual Fall Midwest Thoracic and GI Oncology Conference

NSCLC Practical Tips in Management of Immunotherapy Side Effects on …

Feat. J. Hurley
23:18
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Management of Ground-Glass Opacity Lesions in Lung Cancer

Feat. K. Trujillo
14:03
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Targeting EGFR in NSCLC: Osimertinib, What is the Best TKI Upfront a…

Feat. V. Ernani
17:25
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Targeting ALK in NSCLC: Alectinib 1st Line Treatment Choice, New Pro…

Feat. V. Ernani
14:35
13th Annual Fall Midwest Thoracic and GI Oncology Conference

NSCLC Updated Molecular Testing Guidelines for 2018

Feat. J. Cox
14:20
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Molecular Testing Genes in NSCLC, Emerging Markers and Next Generati…

Feat. J. Cox
18:26
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Immunotherapy in Early Stage NSCLC and PACIFIC Trial of Durvalumab i…

Feat. A. Marr
12:43
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Is There Any Role of Immunotherapy in NSCLC Stage 1 & Stage 2?

Feat. A. Marr
14:11
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Brief History of Robotics in Surgery

Feat. D. Berkheim
07:45
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Robotic Assisted Thymectomy

Feat. D. Berkheim
18:11
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Robotic Assisted Lobectomy

Feat. D. Berkheim
10:58
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Radiology - What Does Ground Glass/Sub-Solid Mean?

Feat. M. DeVries
24:18
13th Annual Fall Midwest Thoracic and GI Oncology Conference

What Processes Can Use Ground Glass and How That Relates to Small Ad…

Feat. W. West
13:06
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Current Recommendations for Follow Up/Management of Sub-Solid Nodules

Feat. M. DeVries
05:55
13th Annual Fall Midwest Thoracic and GI Oncology Conference

Ground Glass/Sub-Solid Nodules Q&A

Feat. W. West, M. DeVries